Oral Administration of Resveratrol-Selenium-Peptide Nanocomposites Alleviates Alzheimer’s Disease-like Pathogenesis by Inhibiting Aβ Aggregation and Regulating Gut Microbiota
Changjiang Li(Jiangxi Agricultural University), Na Wang(Jiangxi Agricultural University), Guodong Zheng(Jiangxi Agricultural University), Licong Yang(Fuzhou University)
Cited by 160
Abstract
. Thus, we anticipate that Res-selenium-peptide nanocomposites will offer a new potential strategy for the treatment of AD.
Related Papers
<i>Faecalibacterium prausnitzii</i> is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
Harry Sokol, Bénédicte Pigneur, Laurie Watterlot et al.|Proceedings of the National Academy of Sciences|2008|4.3k
The cholinergic hypothesis of Alzheimer's disease: a review of progress
Paul T. Francis, Alan M. Palmer, Mike Snape et al.|Journal of Neurology Neurosurgery & Psychiatry|1999|2.2k